Chris Duggleby started his scientific career studying Bacteriology, Virology and Immunology at the Manchester University Medical School. Here he specialised in molecular genetics including research activities into the transfer of multiple antibiotic resistance by plasmids via conjugation (‘sex’) between gut inhabiting Streptococcus faecalis. He also worked on developing mutant bacteria (Pseudomonas methylotrophus) which produce excess ‘essential’ amino acids as part of ICI’s Pruteen (single cell protein) process.
In 1979 he moved out of biotechnology to spend over 35 in the chemicals and oil industries which included setting up a polymers research and development group in Geneva, Switzerland for BP Chemicals International. Following a company sponsored MBA at Warwick University (UK) he then went on to lead a number of international manufacturing and marketing operations in the Chemicals, Plastics and Oil industries. This included being the founding President of Formosa BP Chemicals Corporation in Asia. This was a chemicals manufacturing and marketing joint venture between BP and one of Asia’s largest private manufacturing groups, Formosa.
His work involved living and working in Europe, Asia, the USA, the Middle East, and Russia. More recently he was invited to take on a senior leadership position in the Audit Department of the BP International Oil Group. Here he used his global change and risk management experience to help the group reshape its management structures and processes following a major environmental disaster in the Gulf of Mexico. He has now retired to focus on writing about risk management and producing music in his studios near London, in the Alps and Cape Town. If you are interested in risk management check out his RiskTuition.com or BizChangers.com (management of change) sites. He has also recently launched the JointVentureRisk.com site.
If you tire of reading his medical articles try some of his musical offerings instead. Here is one of Chris Duggleby’s YouTube playlists: